Oneview Healthcare Zukünftiges Wachstum

Future Kriterienprüfungen 5/6

Oneview Healthcare wird ein Gewinn- und Umsatzwachstum von 73.5% bzw. 22.7% pro Jahr prognostiziert, während der Gewinn pro Aktie um 72.6% pro Jahr wachsen soll.

Wichtige Informationen

73.5%

Wachstumsrate der Gewinne

72.6%

EPS-Wachstumsrate

Healthcare Services Gewinnwachstum	23.9%
Wachstumsrate der Einnahmen	22.7%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	29 Apr 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

The Price Is Right For Oneview Healthcare PLC (ASX:ONE) Even After Diving 26%

May 02

Subdued Growth No Barrier To Oneview Healthcare PLC (ASX:ONE) With Shares Advancing 27%

Feb 08

Oneview Healthcare PLC's (ASX:ONE) Business Is Yet to Catch Up With Its Share Price

Dec 06

Here's Why Shareholders Will Not Be Complaining About Oneview Healthcare PLC's (ASX:ONE) CEO Pay Packet

Oct 20

Here's Why We're Watching Oneview Healthcare's (ASX:ONE) Cash Burn Situation

Aug 25

Here's Why We're A Bit Worried About Oneview Healthcare's (ASX:ONE) Cash Burn Situation

Mar 30

Here's Why We're Watching Oneview Healthcare's (ASX:ONE) Cash Burn Situation

Oct 04

We Think Oneview Healthcare (ASX:ONE) Can Afford To Drive Business Growth

Jun 20

Here's Why We're Not Too Worried About Oneview Healthcare's (ASX:ONE) Cash Burn Situation

Oct 11

Will Oneview Healthcare (ASX:ONE) Spend Its Cash Wisely?

Mar 02

Gewinn- und Umsatzwachstumsprognosen

ASX:ONE - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	33	2	2	2	2
12/31/2025	26	-3	-4	-4	2
12/31/2024	23	-6	-6	-6	2
12/31/2023	9	-9	-8	-7	N/A
9/30/2023	9	-10	-8	-7	N/A
6/30/2023	9	-10	-7	-7	N/A
3/31/2023	9	-11	-8	-8	N/A
12/31/2022	9	-11	-9	-9	N/A
9/30/2022	10	-10	-8	-8	N/A
6/30/2022	10	-9	-7	-7	N/A
3/31/2022	10	-9	-6	-6	N/A
12/31/2021	10	-8	-4	-4	N/A
9/30/2021	9	-8	-4	-4	N/A
6/30/2021	7	-8	-5	-5	N/A
3/31/2021	7	-9	-6	-6	N/A
12/31/2020	7	-9	-8	-8	N/A
9/30/2020	7	-12	-11	-10	N/A
6/30/2020	7	-14	-13	-13	N/A
3/31/2020	7	-15	-13	-13	N/A
12/31/2019	7	-17	-14	-13	N/A
9/30/2019	8	-18	-14	-13	N/A
6/30/2019	8	-18	-14	-13	N/A
3/31/2019	8	-19	-17	-16	N/A
12/31/2018	8	-20	-19	-19	N/A
9/30/2018	8	-21	-21	-20	N/A
6/30/2018	8	-22	-23	-22	N/A
3/31/2018	7	-24	-23	-22	N/A
12/31/2017	6	-26	-23	-22	N/A
9/30/2017	6	-25	N/A	-21	N/A
6/30/2017	6	-24	N/A	-20	N/A
3/31/2017	8	-20	N/A	-19	N/A
12/31/2016	9	-16	N/A	-17	N/A
9/30/2016	8	-14	N/A	-14	N/A
6/30/2016	6	-11	N/A	-10	N/A
3/31/2016	4	-10	N/A	-8	N/A
12/31/2015	2	-10	N/A	-5	N/A
12/31/2014	3	-4	N/A	-3	N/A
12/31/2013	0	-1	N/A	-2	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: ONE wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (2.3%).

Ertrag vs. Markt: ONE wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.

Hohe Wachstumserträge: ONE wird voraussichtlich in den nächsten 3 Jahren rentabel werden.

Einnahmen vs. Markt: ONEDie Einnahmen des Unternehmens (22.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Australian (4.9% pro Jahr).

Hohe Wachstumseinnahmen: ONEDie Einnahmen des Unternehmens (22.7% pro Jahr) werden voraussichtlich schneller wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von ONE in 3 Jahren voraussichtlich hoch sein wird

Oneview Healthcare Zukünftiges Wachstum

Future Kriterienprüfungen 5/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates fall by 22%

Recent updates

Independent Non-Executive Director recently sold AU$102k worth of stock

Independent Non-Executive Director exercised options to buy AU$213k worth of stock.

The Price Is Right For Oneview Healthcare PLC (ASX:ONE) Even After Diving 26%

Consensus EPS estimates fall by 22%

Full year 2023 earnings released: €0.02 loss per share (vs €0.021 loss in FY 2022)

Oneview Healthcare Launches MyStay Mobile: A SAAS Product to Revolutionize Digital Patient Experience

Subdued Growth No Barrier To Oneview Healthcare PLC (ASX:ONE) With Shares Advancing 27%

Oneview Healthcare PLC's (ASX:ONE) Business Is Yet to Catch Up With Its Share Price

Independent Interim Chairman recently sold AU$58k worth of stock

CEO & Executive Director exercised options to buy AU$133k worth of stock.

Oneview Healthcare Announces New Version of their Care Experience Platform

Here's Why Shareholders Will Not Be Complaining About Oneview Healthcare PLC's (ASX:ONE) CEO Pay Packet

Oneview Healthcare plc Announces Lyle Berkowitz Will Not Seek Re-Election

Oneview Healthcare PLC to Report Fiscal Year 2023 Final Results on Feb 27, 2024

First half 2023 earnings released: €0.01 loss per share (vs €0.01 loss in 1H 2022)

New major risk - Negative shareholders equity

Here's Why We're Watching Oneview Healthcare's (ASX:ONE) Cash Burn Situation

Oneview Healthcare PLC to Report First Half, 2023 Results on Aug 29, 2023

Oneview Healthcare PLC to Report Q2, 2023 Results on Jul 31, 2023

Oneview Healthcare plc Announces Director Changes

Here's Why We're A Bit Worried About Oneview Healthcare's (ASX:ONE) Cash Burn Situation

Full year 2022 earnings released

Oneview Healthcare PLC, Annual General Meeting, Nov 17, 2022

Here's Why We're Watching Oneview Healthcare's (ASX:ONE) Cash Burn Situation

First half 2022 earnings released: €0.01 loss per share (vs €0.01 loss in 1H 2021)

We Think Oneview Healthcare (ASX:ONE) Can Afford To Drive Business Growth

Oneview Healthcare PLC to Report Q3, 2022 Results on Oct 28, 2022

Oneview Healthcare PLC Appoints Colin Hackwood as New Managing Director for Australia and New Zealand

Full year 2021 earnings released: €0.019 loss per share (vs €0.051 loss in FY 2020)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Independent Lead Director recently sold AU$119k worth of stock

Independent Non-Executive Chairman exercised options and sold AU$275k worth of stock

Here's Why We're Not Too Worried About Oneview Healthcare's (ASX:ONE) Cash Burn Situation

First half 2021 earnings released: €0.01 loss per share (vs €0.03 loss in 1H 2020)

Oneview Healthcare Now Available in the Microsoft Azure Marketplace

Full year 2020 earnings released: €0.051 loss per share (vs €0.13 loss in FY 2019)

New 90-day high: AU$0.21

Oneview Healthcare PLC announced that it expects to receive AUD 1 million in funding from S3 Consortium Pty Ltd

Will Oneview Healthcare (ASX:ONE) Spend Its Cash Wisely?

Full year 2020 earnings released: €0.05 loss per share (vs €0.13 loss in FY 2019)

Oneview Healthcare PLC to Report Fiscal Year 2020 Results on Feb 25, 2021

Oneview Healthcare plc Signs Distribution Agreement with Samsung SDS America, Inc

Oneview Healthcare PLC Announces Resignation of Mark McCloskey from the Board of Directors

Oneview Healthcare PLC Announces Retirement of Mark McCloskey as President, Director and Founder, Effective November 12, 2020

First half earnings released

Oneview Healthcare PLC to Report First Half, 2020 Results on Aug 31, 2020

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken